The mechanism(s) for TKI-insensitivity of CML stem/progenitor cells remain(s) unclear, but may in part be explained by recent data showing that primitive CML cells do not depend on BCR-ABL kinase activity for survival 9,10. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.